An observational study in Silicosis and Pneumoconiosis; Silica, sponsored by University of Oklahoma. Completed at 1 site in United States. Open to participants aged 30 Years and older. Per ClinicalTrials.gov, last updated 2023-12-06.
Sponsored by University of Oklahoma · Observational
Silicosis, a preventable yet irreversible occupational lung disease, has an insidious onset with a latency period for diagnosis extending beyond 10 years from the initial exposure. The central hypothesis of this study is that silicosis cases may currently be going undetected. The long-term goal of this research is to determine the current prevalence and forecast the future prevalence of silicosis and other pneumoconiosis among working populations in Oklahoma and to assist the public health and the healthcare system in planning for a potential resurgence of silicosis.
20 studies on the registry are indexed under Silicosis; 3 are open to participants now.
This study's enrollment of 183 is above the median of 150 across 11 observational studies indexed under Silicosis.
Browse Silicosis studies →University of Oklahoma is the lead sponsor of 432 studies on the registry; 100 are open to participants now.
Of its 42 completed or terminated interventional studies of FDA-regulated products, 16 (38%) have results posted.
Counted across the registry records on this site, refreshed daily.
Primary care clinic, community sample
Participants will be recruited from waiting rooms or other common spaces at participating community health clinics.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Tuberculosis (TB) test: A blood sample is collected for lab testing to determine if you have tuberculosis (QuantiFeron test). Alternatively, the test is done by injecting a small amount of fluid (called tuberculin) into the skin on the lower part of the arm. A person given the tuberculin skin test must return within 48 to 72 hours to have a trained health care worker look for a reaction on the arm.
Also known as: Mantoux skin test, QuantiFeron test
Chest X ray: non-invasive medical test that helps physicians diagnose and treat medical conditions of the lungs and chest. The Chest X-ray will be done to check for abnormalities on the lungs. The test is non-invasive.
A pulmonary function test (PFT, spirometry) is a breathing test that measures how much air your lungs can hold as well as how hard and fast you can blow air out of your lungs. The test is not invasive and involves blowing into a machine.
Also known as: Spirometry, Forced Spirometry
Estimate of average cumulative respirable crystalline silica exposure (semi-quantitative)
Estimate of average cumulative respirable crystalline silica exposure (semi-quantitative)
Time frame: Single point assessment at baseline survey
Percentage of participants who report any exposure to silica
Percentage of participants who report any exposure to silica
Time frame: Single point assessment at baseline survey
Prevalence of silicosis among study group
Percentage of participants with confirmed diagnosis of silicosis
Time frame: Single point assessment at clinic visit
Analysis to determine if any demographic, work history, or other trait correlates with increased silica exposure
Analysis to determine if any demographic, work history, or other trait correlates with increased silica exposure
Time frame: Single point assessment at baseline survey
Plan to share: Yes — Researchers may request a deidentified dataset. The de-identified dataset may be shared between other investigators of the same institution as the PI, in accordance with University and Institutional Review Board policies. Any investigator not affiliated with the University of Oklahoma Health Sciences Center who desires access to a de-identified dataset may do so by coordinating a Data Use Agreement between the investigator's institution and the PI's institution. Datasets will only be released with an active Data Use Agreement or other similar agreement with the University of Oklahoma Health Sciences Center.
Time frame: 2 years after publication
Access criteria: Active Data Use Agreement or other similar agreement with the University of Oklahoma Health Sciences Center
No publications or documents are linked to this record.
Ran from Jan 2019 to primary completion in Feb 2021, 25 months.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Dec 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.